RUSSO, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 2.637
EU - Europa 2.014
AS - Asia 294
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
SA - Sud America 7
Totale 5.069
Nazione #
US - Stati Uniti d'America 2.616
IE - Irlanda 709
IT - Italia 272
UA - Ucraina 206
FI - Finlandia 172
SE - Svezia 167
CN - Cina 131
AT - Austria 126
DE - Germania 119
GB - Regno Unito 107
CI - Costa d'Avorio 98
SG - Singapore 93
BE - Belgio 49
FR - Francia 21
CZ - Repubblica Ceca 19
IN - India 19
VN - Vietnam 18
CA - Canada 17
EU - Europa 10
RU - Federazione Russa 8
ES - Italia 7
IR - Iran 7
NL - Olanda 7
CO - Colombia 5
JP - Giappone 5
LT - Lituania 4
NZ - Nuova Zelanda 4
AU - Australia 3
EE - Estonia 3
KR - Corea 3
LV - Lettonia 3
MY - Malesia 3
RO - Romania 3
BG - Bulgaria 2
IL - Israele 2
LK - Sri Lanka 2
MD - Moldavia 2
MX - Messico 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.069
Città #
Dublin 709
Jacksonville 517
Chandler 474
Wilmington 166
Ann Arbor 143
Vienna 126
San Mateo 120
Helsinki 113
Houston 113
Abidjan 98
Woodbridge 94
Boardman 84
Dearborn 79
Princeton 68
Molise 65
Beijing 51
Brussels 49
Singapore 48
Ashburn 39
Los Angeles 39
New York 30
Rome 24
Dong Ket 16
Spoltore 16
Naples 15
Redwood City 13
Augusta 11
Hefei 10
Jinan 10
Milan 9
Dallas 8
Leawood 8
Shenyang 8
Toronto 7
Auburn Hills 6
Hebei 6
Mountain View 6
Civitanova Marche 5
Nanchang 5
Napoli 5
Amsterdam 4
Ardabil 4
Bogotá 4
Frankfurt am Main 4
Guangzhou 4
Kunming 4
London 4
Nanjing 4
Zhengzhou 4
Auckland 3
Caserta 3
Centro 3
Falkenstein 3
Forio 3
Genova 3
Monmouth Junction 3
Norwalk 3
Ottawa 3
Pescara 3
Philadelphia 3
Riga 3
Rockville 3
San Giovanni Rotondo 3
Tallinn 3
Udine 3
Wuhan 3
Bangalore 2
Bengaluru 2
Borås 2
Bratislava 2
Campobasso 2
Campoformido 2
Cassino 2
Changsha 2
Chisinau 2
Colombo 2
Isernia 2
Islamabad 2
Kuala Lumpur 2
Lappeenranta 2
Melbourne 2
Mumbai 2
Newark 2
Noicattaro 2
Paris 2
Phoenix 2
Saint-Fons 2
Salerno 2
San Francisco 2
Seattle 2
Sofia 2
Tappahannock 2
Turin 2
Viterbo 2
West Hartford 2
West Jordan 2
Afragola 1
Aguascalientes 1
Almaty 1
Arese 1
Totale 3.564
Nome #
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 148
Analysis of protease levels in brain samples from Alzheimer’s patients 142
METODO PER RILEVARE LA PRESENZA E LA QUANTITA DEL RECETTORE LRP8 E DEI SUOI FRAMMENTI PROTEOLITICI, KIT DI RILEVAMENTO E RELATIVI ANTICORPI 134
Serum levels of acyl-carnitines along the continuum from normal to Alzheimer's dementia 131
Complexity and Selectivity of γ -Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer 131
Levels of acyl-carnitines in serum of patient with or at risk of Alzheimer’s disease. 111
Magnetic Resonance Imaging correlates of benign and malignant alterations of the spinal bone marrow 110
Proteases Upregulation in Sporadic Alzheimer's Disease Brain 105
Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death 98
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 93
The "Alzheimer's disease signature": potential perspectives for novel biomarkers 89
Pyroglutamate-modified amyloid β-peptides - aβN3(pE) - strongly affect cultured neuron and astrocyte survival 88
Alzheimer's disease: Molecular consequences of presenilin-1 mutation 85
The β-amyloid precursor protein APP is tyrosine phosphorilated in cells expressing a constitutively active form of the Abl protoncogene 84
Imaging of metabolic bone disease 84
Adiponectin as novel regulator of cell proliferation in human glioblastoma 82
Persistent increase of d-aspartate in d-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 81
N-Terminally truncated amyloid b peptides and Alzheimer's disease 81
Amyloid-beta Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau 81
Presenilin1 modulation of amyloid precursor protein processing: occurrence and relevance of N-truncated β-amyloid and carboxy-terminal fragments in AD pathology 80
Enhancement of Glycine release from human brain cortex by acetylcholine acting at M4 muscarinic receptors 80
The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications 79
Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling 77
Presence of soluble amyloid b peptide precedes amyloid plaque formation in Down’s syndrome 77
NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion 77
BACE-2 is overexpressed in Down's syndrome 76
Farmaci nella terapia della demenza di Alzheimer 75
Selection of Candidate Housekeeping Genes for Normalization in Human Postmortem Brain Samples 75
Bace overexpression regulates amyloid precursor protein cleavage and interaction with ShcA adapter 74
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 73
Presenilin-1 mutations in Alzheimer's disease 73
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain 73
Apoptotic cell death influences the signaling activity of the Amyloid Precursor Protein through ShcA and Grb2 adaptor proteins in neuroblastoma SH-SY5Y cells 73
Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease 73
a-Glycerylphosphorylethanolamine rescues astrocytes from mitochondrial impairment and oxidative stress induced by amyloid b-peptides 71
Molecular aspects of neurodegeneration in Alzheimer’s disease 70
Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro 70
Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid β-peptides induced oxidative stress and reduces NF-kB activation 69
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain 68
Human brain amyloidoses 68
An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples 66
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid β-protein precursor 65
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia. 64
A novel snRNA-like transcript affects amyloidogenesis and cell cycle progression through perturbation of Fe65L1 (APBB2) alternative splicing. 63
Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformational diseases 63
Amyloid precursor protein modulates ERK1/2 signaling 62
Efficacy of Novel Acridine Derivatives in the Inhibition of hPrP90-231 Prion Protein Fragment Toxicity 61
RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration 61
Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231 60
Apoptotic cell death and Amyloid Precursor Protein signaling in neuroblastoma SH-SY5Y cells 59
Amyloid precursor protein and Presenilin 1 interaction studied by FRET in human H4 cells 58
Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran 57
Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling 57
Identification of amino-terminally and phosphotyrosine modified carboxy-terminal fragments of the amyloid precursor protein in Alzheimer’s disease and Down’s syndrome brain 57
Conformation dependent pro-apoptotic activity of the recombinant human prion protein fragment 90-231 57
Amyloid precursor protein and presenilin involvement in cell signaling 57
Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants 56
ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation 55
Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects 55
Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein 53
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain 53
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome 51
Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic 51
Beta amyloid is different in normal aging and in Alzheimer's disease 46
Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231 46
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells 42
Severe hypotension, bradycardia and asystole after sugammadex administration in an elderly patient 39
Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System 37
Sudden cardiac death caused by a fatal association of hypertrophic cardiomyopathy (Myh7, p.arg719trp), heterozygous familial hypercholesterolemia (ldlr, p.gly343lys) and sars-cov-2 b.1.1.7 infection 37
Reply to Sagliocco, O.; Betelli, M. Comment on “Fierro et al. Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient. Medicina 2021, 57, 79” 36
Innovative Phospholipid Carriers: A Viable Strategy to Counteract Antimicrobial Resistance 14
αS1-Casein-Loaded Proteo-liposomes as Potential Inhibitors in Amyloid Fibrillogenesis: In Vivo Effects on a C. elegans Model of Alzheimer’s Disease 1
Totale 5.148
Categoria #
all - tutte 25.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020512 0 0 0 0 70 49 148 38 83 41 10 73
2020/2021658 9 65 2 91 90 49 73 2 80 12 134 51
2021/2022410 41 95 13 40 27 26 9 30 72 20 11 26
2022/20231.869 201 67 27 186 134 161 1 78 873 70 36 35
2023/2024328 60 41 16 7 29 47 10 35 5 24 3 51
2024/2025360 118 36 184 14 8 0 0 0 0 0 0 0
Totale 5.148